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Abstract
Touch spray mass spectrometry using medical swabs is an ambient ionization technique 
(ionization of unprocessed sample in the open air) that has potential intraoperative application in 
quickly identifying the disease state of tissue and in better characterizing the resection margin. To 
explore this potential, we studied 29 human brain tumor specimens and obtained evidence that this 
technique can provide diagnostic molecular information that is relevant to brain cancer. Touch 
spray using medical swabs involves the physical sampling of tissue using a medical swab on a 
spatial scale of a few mm2 with subsequent ionization occurring directly from the swab tip upon 
addition of solvent and application of a high voltage. Using a tertiary mixture of acetonitrile, N,N-
dimethylformamide, and ethanol, membrane-derived phospholipids and oncometabolites are 
extracted from the tissue, incorporated into the sprayed microdroplets, vacuumed into the mass 
spectrometer, and characterized in the resulting mass spectra. The tumor cell load was assessed 
from the complex phospholipid pattern in the mass spectra and also separately by measurement of 
N-acetyl-aspartate. Mutation status of the isocitrate dehydrogenase gene was determined via 
detection of the oncometabolite 2-hydroxyglutarate. The lack of sample pretreatment makes touch 
spray mass spectrometry using medical swabs a feasible intraoperative strategy for rapid surgical 
assessment.
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Introduction
We describe the rapid analysis of neurological tissue by touch spray mass spectrometry with 
medical swabs (i.e., swab TS-MS). Swab TS-MS is envisioned as a tool for molecular 
diagnosis of gliomas in which tissue is sampled in vivo along the surface of the resection 
cavity, and then analyzed intraoperatively but ex vivo to provide rapid feedback on the 
pathological state of the tissue and to guide surgical maneuvers for maximal tumor excision. 
Added diagnostic information for surgical margin assessment is provided by these chemical 
measurements to complement standard intraoperative histopathology. Intraoperative 
histopathology, as currently performed during neurosurgical tumor resection, identifies 
tumor type and grade from tumor core tissue, but it is not used for assessment of surgical 
margins. Surgical margins are defined based on the surgeon’s experience, visual and tactile 
observation of the tissue during surgery, and neuronavigation according to preoperative 
MRI.1–4 No intraoperative molecular measurement indicative of tissue pathology is currently 
made to assist in surgical decision-making.
Here we present the swab TS-MS methodology for analysis of neurological tissue and 
provide proof-of-concept data of its diagnostic utility from 29 human brain specimens 
selected for their known histopathology. Swab TS-MS is an ambient ionization method in 
which a minute amount of sample (e.g., tissue) is transferred to a swab tip by a gentle touch, 
and subsequently ionized with the application of solvent to the swab tip and a high voltage 
directly to the swab shaft.5, 6 Sampling is minimally invasive, analysis is straightforward and 
requires no other sample handling or pretreatment, making it highly appropriate for clinical 
testing in hospitals.7 Swabs are used both as sampling devices and as electrospray emitters 
for MS analysis. Rapid evaporative ionization mass spectrometry (REIMS) combines tissue 
sampling and ionization in an online approach to provide quasi real-time feedback.8 In 
REIMS, a modified monopolar cutting electrode is used for both tissue removal and for 
collection of the surgical smoke produced from electrocauterization.8 We envision swabs as 
a tool to maximize analysis throughput while removing the need for positioning the MS 
instrument close to the surgical field or requiring a transfer line to interface the ionization 
source to the mass spectrometer. We consider an offline approach, where tissue sampling is 
performed remotely from the mass spectrometer, to best suit neurosurgery needs while 
limiting deviations from current surgical procedures.
Swab touch spray is based on the ambient ionization method of paper spray mass 
spectrometry9 which has proven successful in biofluids analysis. Applications of swab TS-
MS that have been presented so far include the detection of microbial lipids from culture5 
and from human skin, and illicit drug detection in oral fluid.6 The development of swab TS-
MS follows that of TS and probe electrospray ionization (PESI), two methods that use 
metallic teasing probes for tissue sampling. TS in this previous form has been investigated 
for prostate and kidney cancer detection10–12 while PESI has been tested for detection of 
renal cell carcinoma and metabolite profiling in mouse brain.13, 14 Differently from metal 
probe TS and PESI, swab TS utilizes swabs that are already commercialized as probes for in 
vivo sampling of deep surgical wounds, body orifices and surfaces, facilitating the 
translation of this tool into surgical application. Electrospray ionization occurs readily from 
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the porous material of the swab tip, similarly to paper spray15, 16 and biocompatible solid 
phase micro-extraction fibers.17, 18
Three items of information were sought from the mass spectra obtained using swab TS-MS: 
(i) tissue type was assessed by monitoring the expression of complex phospholipids; (ii) 
tumor infiltration was measured as percentage of tumor cells (TCP; relative percentage of 
tumor cells compared with parenchyma) by monitoring the abundance of N-acetylaspartate 
(NAA); and (iii) isocitrate dehydrogenase (IDH) mutation status was assessed by monitoring 
the presence of the oncometabolite 2-hydroxyglutarate (2HG). Previous studies using 
desorption electrospray ionization-mass spectrometry (DESI-MS) demonstrated that all 
three items of diagnostic information are achievable by electrospray-based ambient 
ionization MS19–22 and that this technology can be used for intraoperative molecular 
pathology.23–25 DESI-MS is emerging as a molecular diagnostic intraoperative tool for 
analysis ex vivo of biopsied tissue smears. Phospholipid profiles, as detected by DESI-MS, 
change dynamically with the density of the tumor and with the composition of the infiltrated 
brain parenchyma (i.e., grey matter, white matter, or a mixture of both). NAA signal 
intensities in DESI mass spectra decrease proportionally with the degree of tumor 
infiltration, measured as TCP.20, 21, 23 The oncometabolite 2HG accumulates in glioma 
tissue carrying IDH mutations.26 Its presence has been determined using DESI-MS and the 
data compared well with clinical genetic tests carried out post-operatively.22 The 
development of swab TS-MS, also an electrospray-based method, represents an additional 
step towards the use of intraoperative MS and it provides the neurosurgeon with a simple 
manual tool for in vivo tissue sampling and direct chemical evaluation of tissue pathology.
Experimental
Study protocol
Cryopreserved human neurological specimens were obtained from 29 patients through the 
Biorepository of the Methodist Research Institute (Purdue IRB #1410015344). The list of 
specimens analyzed in this study is reported in Table S1. Tissue specimens were stored at 
−80 °C before analysis. For each specimen, a few tissue sections (15-μm thickness) were cut 
using a cryotome (Cryotome™ FSE Cryostats, Thermo Fisher Scientific, San Jose, CA) in 
order to obtain a flat open surface of the tissue. The last tissue section cut was H&E stained 
for blind pathological examination. The tissue sample was then allowed to thaw at room 
temperature, and the flat surface of the tissue, adjacent to the section that was stained, was 
touched with the swab (approximately an area of 6 mm2) to perform the TS-MS 
experiments. Multiple touches were performed for most of the samples that showed 
macroscopically-heterogeneous areas, as detailed in Table S1. For all the specimens used in 
this study, another tissue biopsy had been previously used for preparation of tissue sections 
and smears and analyzed by DESI-MS imaging. Results are reported elsewhere.19, 20 Mouse 
brain (Purdue IRB #1704001561) was used for the initial stages of method development.
Chemicals
Electrospray was generated using a mixture of acetonitrile-dimethylformamide-ethanol 
(ACN-DMF-EtOH) in a ratio of 45:5:50 % v/v, doped with octyl β-D-glucopyranoside (non-
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ionic surfactant, ≥98% pure) and the internal standard NAA-d3, (10 μg/mL). All solvents 
and standards were purchased from Sigma Aldrich (Minneapolis, MN).
Medical swabs
Sterile medical swabs were purchased from Copan Diagnostics Inc. (Murietta, CA). The 
swabs have an aluminum handle and rayon mini tip of fused shape and largest diameter of 
~2.4 mm (Fig. S1). The swabs are packaged in individual tubes for easy transport and 
storage. They are mounted in a plastic cap that serves as a convenient holder. Each tube and 
cap assembly is sealed with a tamperproof label for assurance of sterility and chain of 
custody. These swabs are commercialized for purposes other than ESI probes for MS 
analysis. They have been used with no modification from their commercial form.
Swab touch spray mass spectrometry
Swab touch spray experiments were performed by touching gently a region of interest of a 
sample and rotating the swab on its shaft to transfer minute quantities of tissue on the swab 
tip. Each swab was weighed before and after the touch to measure tissue quantity transferred 
to the swab tip (Tissue Weight, Table S1), and then submitted to MS analysis with no further 
treatment.
MS experiments were performed using a linear ion trap mass spectrometer (Finnigan LTQ, 
Thermo Fisher Scientific). The ion source was custom-built to allow positioning the swab 
vertically with respect to the mass spectrometer; a configuration similar to that used in 
commercial electrospray sources. The use of an extended MS inlet capillary, bent 90° 
upwards and held directly underneath the swab tip, improved stability of the swab 
electrospray despite ion transmission losses (Fig. S2). The absence of carry-over using a 
bent inlet capillary was tested by spraying concentrated mouse brain extracts (1 mg/mL in 
ACN-DMF-EtOH 45-5-50 % v/v) using a clean swab as probe substrate, in alternation with 
blank solvent. The swab tip was positioned 5–8 mm above the inlet. A precision motion 
control system was used to adjust the position of the swab whenever necessary. A silica 
capillary was used to deliver the solvent to the swab tip using an external syringe pump. The 
silica capillary was held in a fixed position in such a way that the end of the capillary 
directly touched the surface of the swab tip once positioned. Electrospray was generated 
using ACN-DMF-EtOH 45:5:50 % v/v as solvent system. The solvent was doped with 250 
ng/mL of octyl β-D-glucopyranoside to facilitate solvent flow on the probe, and 10 μg/mL of 
the internal standard NAA-d3. Electrospray was initiated after addition of solvent directly on 
the swab tip via a fused silica capillary and external syringe pump. The syringe pump flow 
rate was set at 50 μL/min for about 30 s, accounting for dead volume and wetting the swab 
tip. When the swab tip was visibly wet, high voltage (−6.5 kV) was applied directly to the 
metallic handle. Solvent flow rate was changed to 25 μL/min. It was possible to generate an 
electrospray from all the swabs analyzed. In only a couple of instances fibers distend from 
the body of the swab tip during data acquisition compromising the stability of the 
electrospray; these swabs had to be disregarded and the experiments repeated.
Full scan mass spectra over the range m/z 700–1000 were acquired in negative ion mode 
first; a second acquisition over the mass range m/z 80–200 was performed in negative ion 
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mode. After this, collision-induced dissociation MS/MS product ion scans were acquired to 
measure NAA (precursor ion m/z 174 [M-H]−) and NAA-d3 (precursor ion m/z 177 [M-
H]−), followed by MS3 sequential product ion scans of 2HG (precursor ion m/z 147 [M-
H]−). Total acquisition time was 1.2 min; approximately 15 seconds were acquired for each 
mode so that spray and signal stability could be evaluated. MSn spectra other than for NAA 
and 2HG were acquired separately when additional structural information was needed for 
compound identification. The automatic gain control was always activated to adjust for 
variable ion flux. The MS instrumental settings are reported in Table S2. Signal-to-noise 
ratios were calculated using ion intensity at maximum peak height and signal intensity at 
peak onset.
Microscopic videography
For each swab tested, videos of the spray plume were recorded to observe the electrospray 
behavior. A Watec WAT-704R camera was used to acquire the videos; the software 
Cyberlink PowerDirector v.14 (www.cyberlink.com) was used to record them; Adobe 
Premier Pro CC (www.adobe.com) was used for video editing. The spray plume was 
illuminated with a red laser pointer as shown in Fig. S2.
Data analysis and chemical diagnosis
Data were exported from XCalibur 2.0 (Thermo Fisher Scientific) and imported into 
MATLAB (The Matworks Inc., Natick MA) for elaboration. Full scan mass spectra were 
used to provide molecular diagnosis of the tissue via comparison with a reference spectral 
library acquired by DESI-MS. Spectral profiles were used comprehensively to classify the 
tissue as either glioma, white matter, or grey matter. The methodology is based on 
multivariate pattern recognition and is described extensively elsewhere.20, 21 The abundance 
of NAA, detected using tandem MS (m/z 174→114) and normalized to the intensity of the 
internal standard NAA-d3 (m/z 177→116), was plotted in relation to tumor infiltration (low, 
medium, and high as evaluated by histopathology). Box-plots were created using MATLAB. 
The Krushall-Wallis non-parametric test was used to compare population medians. P values 
<0.05 were considered significant. The signal intensity of 2HG, detected using MS3 (m/z 
147→129→101) and normalized to the intensity of the internal standard NAA-d3 (m/z 
177→116), was plotted against the IDH mutation status (wild-type vs IDH mutant) to 
monitor differential distribution. The receiver operating characteristic (ROC) curve analysis 
was used to determine the ability of 2HG measurement to assess IDH mutation of gliomas. 
The predicting ability was considered strong when the area under the curve (AUC) exceeded 
0.8 (80%). Receiver operating characteristic (ROC) curve analysis and Kruskal-Wallis test 
were performed using SPSS v.22 (SPSS Inc. IBM Corp, Chicago, IL).
Adobe Photoshop (Adobe Systems Inc., San Jose, CA) was used to produce publication-
quality figures.
H&E staining
Tissue staining was performed as described elsewhere.20
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Histopathology
An expert neuropathologist (E.M.H.) identified regions of interest as glioma (G) or 
infiltrated tissue (IT), further specifying grey matter (GM), white matter (WM), a mixture of 
both, or infiltrated tissue not otherwise specified (NOS). Estimation of tumor cell percentage 
was roughly provided in the categories of low (<33%), medium (34–67%), or high (>67%) 
simply by visual observation. Immunohistochemistry for assessment of IDH mutation was 
performed on separate tissue biopsies than those analyzed by swab TS-MS. Analysis was 
conducted from an independent pathology laboratory. Results were provided from the 
Biorepository of the Methodist Research Institute as dichotomous answer (immunoreactive 
vs. non-immunoreactive, Purdue IRB #1410015344).
Results
Instrumental set-up and analytical considerations
Swab TS-MS was performed in such a way as to mimic one foreseeable implementation: 
collection of tissue in vivo along the surface of the resection cavity, followed by placement 
of the swab probe in front of a mass spectrometer located in the operating room and direct 
MS analysis (Fig. 1). Analysis required a few minutes with the current methodology; this 
time was equally divided between swab positioning onto a custom-built source and MS data 
acquisition, while tissue sampling was immediate. MS data acquisition was prolonged for 
over a minute to test electrospray and signal stability but could be shortened to a few 
seconds for each mode of data acquisition, since the entire tissue sampled on the swab is 
interrogated by the constantly-flowing solvent, leading to a chemical profile that is stable 
over time and represents the average signature arising from the heterogeneous 
morphological features sampled. The analysis can be multiplexed easily, as done in this 
study, to specifically monitor particular biomarkers and oncometabolites. In this study, 
cryopreserved tissue biopsies served as a proxy for in vivo sampling. Swab TS-MS 
incorporates a manual user-guided method of collecting minute amounts of tissue with direct 
MS analysis from the sampling device. A current drawback of this approach is the lack of 
control over the quantity of tissue transferred on the swab tip by touch. The average quantity 
for the specimens analyzed in this study was 3.1 mg but acceptable signal-to-noise ratios 
(>3) for the diagnostic peaks in the mass spectra were obtained for as little as 1.0 mg. Tissue 
quantities are minimal and smaller than those of a typical tissue biopsy resected for 
pathological examination. The minute amount of sample collected emphasizes the value of 
MS methods in which ionization is generated directly from the sampling device; viz., no 
sample loss and higher signal intensity resulting from minimal solvent consumption (flow 
rate ~25 μL per minute). Table S1 gives the signal-to-noise ratios calculated on the most 
intense peak of the lipid profile mass spectra. As already observed using DESI-MS,21, 28 the 
absolute signal intensity changed with the quantity of tissue sampled, as well as with its 
composition and cellularity. High-grade and high-density tumor tissue provided lower 
absolute signal compared to low-infiltrated tissue, partly due to the presence of calcified, 
hemorrhagic, and necrotic tissue. Note that an internal standard added to the extraction 
solvent normalizes variations of absolute ion counts due to swab positioning and instability 
of the electrospray, but cannot correct for matrix differences. Importantly, the relative 
spectral profiles (i.e., relative intensity of ions within a scan) used as a diagnostic fingerprint 
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of the tissue were grossly uninfluenced by global intensity variations which allowed us to 
obtain accurate diagnostic information from the mass spectra despite the lack of control over 
the absolute quantity of tissue analyzed. We monitored the spectral profiles repeatedly over a 
total period of 10 minutes in both low- and high-glioma infiltrated samples and changes in 
their respective spectral profiles were minimal (relative standard deviations <15% for 
diagnostic ions, Fig. S3). The absolute signal decreased monotonically over time, which is 
typical of a continuous extraction process (Fig. S4).
Different extraction solvents (methanol, ACN, DMF, EtOH, dichloromethane, and acetone) 
were tested during method development based on previous experience with DESI-MS.27 The 
system empirically chosen for these analyses (ACN-DMF-EtOH, 45:5:50 v/v%) is the result 
of an optimization process meant to select a mixture of organic solvents that would provide a 
chemical fingerprint of the tissue similar to that obtained using DESI-MS (which uses ACN-
DMF 50:50 v/v% as solvent system) but one that would also generate an electrospray from 
the swab tip. Video S1 shows the generation of the electrospray plume from the swab and its 
remarkable stability. The caption describes briefly the swab electrospray process 
(Supplementary Material, Video S1). The use of the original ACN-DMF DESI solvent was 
not acceptable because of poor spray behavior observed in the negative ionization mode for 
swab TS-MS. The addition of ethanol and a non-ionic surfactant to the solvent system 
significantly decreases the surface tension of the solvent mixture, thereby facilitating 
electrospray plume formation from the swab tip and improving signal stability.
Assessment of glioma presence and estimation of tumor infiltration
The lipid profiles detected by swab TS-MS resembled those detected by DESI-MS.20 They 
indicated the presence of tumor when present and could distinguish the type of normal tissue 
into which the tumor infiltrated (i.e., grey matter or white matter); an information not always 
assessable by histopathology as tumors efface the morphology of normal brain parenchyma. 
The main MS feature characterizing grey matter is m/z 834.5, the deprotonated ion of 
phosphatidylserine 40:6 (Fig. 2A). The main MS features characteristic of white matter are 
m/z 888.6 and 904.5, deprotonated ions for (3′-sulfo)GalCer 24:1 and (3′-sulfo)GalCer 
24:1(OH) (Fig. 2B). For gliomas, the characteristic ions are m/z 768.4, the chlorinated 
adduct of phosphatidylcholine 32:0, m/z 794.5, chlorinated adduct of phosphatidylcholine 
34:1, and m/z 885.5, the deprotonated phosphatidylinositol 38:4 (Fig. 2C). Figure S5 shows 
spectra for these categories of samples acquired by DESI-MS for comparison. The similarity 
between the lipid profiles acquired by DESI-MS and swab TS-MS for the same subjects 
(from different portions of tissue biopsies) was measured in terms of spectral correlation 
using canonical correlation analysis12, 20 and the correlation coefficient was equal to 0.9.
High-resolution MS and MS2 experiments have been previously recorded using DESI-MS 
for structural identification.20 These experiments were repeated using swab TS-MS and 
confirmed the structural assignments (Fig. S6). Increased intensity of m/z 810.4, 
corresponding to phosphatidylserine 38:4 was observed in a few specimens. We attribute it 
to blood absorption on the swab tip as this lipid is a major membrane constituent of 
erythrocytes. This interference did not compromise our ability to determine the presence of 
tumor in the tissue but further evaluation is needed from specimens collected in vivo.
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The neurometabolite NAA is one of the most abundant in healthy human brain tissue. 
However, its abundance (i.e. relative signal) observed in swab TS mass spectra decreased as 
the TCP (i.e., tumor cells relative to normal cells) increased (Fig. 3). Population medians are 
statistically different (p values=0.0046 using Kruskal-Wallis non-parametric test). NAA 
measurement provides an estimate of tumor infiltration within the tissue, and corroborates 
prior DESI-MS observations made on tissue sections and smears,20, 21, 23 as well as 
literature reports regarding the inhibited expression of the biosynthetic enzyme L-aspartate 
N-acetyltransferase in glioma cells.29 For validation, we confirmed that the decreased signal 
abundance of NAA in the swab TS-MS spectra corresponded to decreased concentrations of 
NAA in the specimens. We quantified NAA in the same specimens using an independent 
protocol, which is described elsewhere.30 Briefly, an adjacent portion of the tissue to that 
sampled by swab TS-MS was removed and extracted using methanol-water (3:2 v/v). The 
solution was analyzed by traditional electrospray ionization triple quadrupole MS operated 
in the multiple reaction monitoring (MRM) mode. NAA concentrations decreased 
proportionally with increasing fraction of tumor cells (averages for low, medium, and high 
TCP were equal to 797, 406, and 42 ng/mg, respectively), hence validating the trend we 
observed qualitatively in swab TS mass spectra (see results in Table S3). A more accurate 
regression analysis to estimate tumor infiltration is yet to be developed, as is assessment of a 
detection limit for the minimal and maximum amounts of infiltrating cells discernable via 
NAA measurements. The use of controlled cell cultures and mixtures is foreseen as a 
possible strategy to address such issues.
Overall, the changes in the lipid and NAA features in swab TS-MS spectra reflect the known 
complexity and heterogeneity of gliomas that diffusely infiltrate into the surrounding brain 
parenchyma, as corroborated by pathological examination of the tissue (Table S1). Figure 4 
depicts an example of such dynamic yet diagnostic changes. Three regions of interest were 
sampled from Case #19. The touch spray at the first spot (Sample #31) showed a low 
abundance of NAA (indicative of high TCP) and a lipid profile indicative of glioma tissue 
infiltrating grey matter (Fig. 4A and 4B). The second spot touched (Sample #32) showed 
low abundance of NAA as well but the lipid profile was indicative of glioma invading a 
mixture of white and grey matter (Fig. 4D and 4E). The third touch (Sample #33) showed 
higher intensity of NAA (lower tumor infiltration) into prevalently grey matter, as indicated 
by the lipid profile dominated by m/z 834.5 (Fig. 4G and 4H). Pathological examinations 
matched with the swab TS-MS results (Table S1).
Assessment of IDH mutation via 2HG measurement
IDH mutations result in accumulation of 2HG in glioma cells by conversion of alpha 
ketoglutarate via NADPH oxidation. We detected a 50-fold increase in the average 2HG 
normalized signal intensity between wild-type gliomas and IDH-mutant gliomas (Fig. 5A). 
A wide range in 2HG signal intensity was detected for the IDH-mutant gliomas and can be 
attributed to differences in tissue cellularity and the known heterogeneity of tumor density in 
the samples. We averaged the 2HG measurements of multiple touches from the same 
specimens to avoid bias due to sample size (N=29). The possibility that other compounds 
give ions that interfere with the signal for 2HG in the full scan mass spectrum led us to 
increase specificity by using the MS3 collision-induced dissociation sequence m/z 
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147→129→101. A sequential product ion scan spectrum from an IDH-mutant glioma is 
shown in Figure S7. A relative signal intensity of 2HG (signal intensity of the sequential 
product ion m/z 147→129→101 normalized to the signal intensity of the internal standard 
NAA-d3 m/z 174→114) equal to 1.02 is a cut-off that discriminates this set of IDH-mutant 
gliomas and wild-type gliomas with 100% accuracy (using ROC curve analysis). This 
observation was confirmed by quantitation of 2HG in adjacent tissue of the same specimens, 
performed as described above for NAA (N=28; Case #29 was excluded because insufficient 
tissue was available to perform both experiments). A cut-off of 45 ng/mg for the 2HG 
concentrations was found to discriminate IDH-mutant and wild-type tumors with 100% 
accuracy.30 Concentrations of 2-HG are reported in Table S3 for validation. Figure 5B shows 
complete agreement between the qualitative swab TS-MS measurements and the 
concentrations determined by ESI-MS (i.e. all IDH mutant samples show swab TS-MS 
intensity and ESI-MS concentrations of 2HG above the set cut-offs, while wild-type tumors 
show values below such cut-offs). There is also agreement with intraoperative DESI-MS 
measurements reported recently.23
Discussion
In this study, we demonstrated the feasibility of obtaining accurate diagnostic information 
(Table S4) by touching tissue using a medical swab followed by direct MS analysis from the 
sampling device. Rapid analysis and minimally invasive sampling are major advantages of 
swab TS-MS. A larger cohort of samples is certainly needed to validate the findings 
described herein and to evaluate its use in routine clinical practice. Nonetheless, we consider 
this technique to be worth investigating as a strategy to implement chemical pathology into 
the standard intraoperative diagnostic consultation. The collection of tissue remotely to the 
mass spectrometer using a medical swab is a simple process. Changes to the swab design 
and the source interface could improve automation and reduce analysis time. MS analysis of 
neurological tissue directly from the sampling device can be performed inside the operating 
room with no interference with surgical practice. Commercial MS instruments and ESI 
sources can easily be adapted to allocate the swab as probe rather than the conventional ESI 
needle. Rapid analysis of tissue should allow assessment of the surgical margin status in 
multiple locations selected by the neurosurgeon as tumor resection is executed. The 
diagnostic feedback can provide guidance on further surgical maneuvers to maximize safe 
tumor resection, especially in proximity of critical anatomical structures. Neurosurgeons are 
already familiar with the use of swabs and absorbent pads and the device we are describing 
to touch neurological tissue would be used no differently. A fit-for-purpose swab design is 
wanted, however, for optimal MS performance. The medical swab we used in this study is 
commercialized as a class IIA device for surgical invasive transient use (i.e., contact with 
tissue for less than 60 min). The swab has a sterile mini rayon tip with a fused shape. It is 
sufficiently small to sample minute amounts of tissue by gentle touch and minimize the 
invasiveness of the sampling procedure but tip dimensions could be reduced further and the 
shape of the tip changed to a conical geometry to improve upon electrospray formation. The 
stiffness and the crevasses in the tip hold the tissue during sample transfer and MS analysis, 
but different biocompatible functionalized surfaces could be designed to improve tissue 
transfer, reduce chemical noise, and enhance extraction and recovery of target compounds. 
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The aluminum handle is conductive and allows the generation of the electrospray directly 
from the swab upon application of a high voltage; a different design of the swab with 
hollowed handles could facilitate the delivery of solvent and allow for the development of a 
swab probe that is easier to interface with commercial ESI sources.
The spectra obtained from swab TS-MS recapitulate previously reported DESI-MS spectra 
and pathology. The lipid signature provides information as to the disease state of the tissue. 
The oncometabolite NAA provides estimate of tumor infiltration which is of utmost 
importance when attempting to maximize glioma resection, an outcome that is favorably 
prognostic for glioma patients. Our results support the hypothesis that tumor infiltration can 
be monitored through neuronal cell damage in its path by measuring NAA depletion.31 
Estimation of tumor infiltration directly from points of interest along the resection margins 
can guide further tumor excision, assisting and validating neurosurgeons’ decisions; keeping 
in mind that complete tumor resection is unachievable, and safe removal of tissue with high 
tumor infiltration is a primary goal of neurosurgery, whereas areas of low infiltration are 
more likely to be the target of coadjuvant postsurgical therapies. In the current surgical 
practice, the amount of residual tumor near the resection margins is not pathologically 
assessed during surgery. Neuronavigation with preoperative MRI images is typically used to 
judge extent of resection but several studies have highlighted the limitations and the 
subjectivity of such a practice as tumor infiltration can extend beyond MRI contrast-
enhanced areas, and the enhancement itself poorly correlates to tissue histopathology.3, 4 In 
our parallel work using DESI-MS, we were able to detect variable and even large amounts of 
residual tumor via NAA measurements at the resection margins, even when they appeared 
clear and non-enhanced by postoperative MRI,23 remarking the utility of such a 
measurement.
In addition to tumor presence and infiltration, we can monitor the oncometabolite 2HG to 
assess the IDH mutation status of the tumor which is clinically relevant and a strong 
prognostic marker.26, 32 IDH mutation status is normally assessed postoperatively as it relies 
on laborious immunohistochemistry or genetic assays on biopsied tissue; however, its 
intraoperative assessment via MS measurement of 2HG could influence surgical decisions. 
An increasing body of evidence shows that more aggressive resection of IDH-mutant 
gliomas improves overall and progression-free survival, while more aggressive resection of 
wild-type tumors does not.33, 34 Furthermore, the assessment of IDH mutation is required 
for tumor diagnosis following the 2016 WHO diagnostic criteria for central nervous system 
tumors.35 Intraoperative testing could benefit neuropathologists by providing a more 
accurate diagnostic consultation, for example, achieving an unequivocal diagnosis of diffuse 
glioma intraoperatively, particularly at the edge of a tumor. This is very challenging by 
pathology and often results in a nonspecific diagnosis. Having concurrent access to 
supporting molecular information should bolster the diagnostic yield. In addition, it is 
conceivable that emerging intraoperative therapies (e.g., BCNU wafers)36 may require better 
classification of diffuse gliomas intraoperatively to guide better decision making.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Swab TS-MS experiment
(Left to right) Tissue is touched with the swab tip and transferred by rotating the swab on its 
shaft. The swab is positioned in front of a mass spectrometer and an electrospray is 
generated directly from the swab tip upon application of solvent and a high voltage, which 
allows mass spectra to be recorded.
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Fig. 2. Full-scan mass spectra in negative ion mode over m/z 760–920
(A) Sample #24; pathological assignment: grey matter with low TCP. (B) Sample # 1; 
pathological assignment: white matter with low TCP. (C) Sample #20; pathological 
assignment: glioma with high TCP. Y-axes are normalized to the base peak (m/z 834, 888, 
and 794, respectively) in the mass range m/z 760–920. TIC values are 7.98·106, 6.71·106, 
and 2.22·105 respectively for A, B, and C.
Pirro et al. Page 14
Analyst. Author manuscript; available in PMC 2018 October 23.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 3. Box and whisker plot
NAA abundance in tissue was categorized as low (<34%, n=24), medium (34–67%, n=12) or 
high (>67%, n=11) TCP as visually assessed by histopathology. Note, multiple touches from 
the same specimens were considered independent measurements as the neuropathologist 
annotated the presence of heterogeneous areas in adjacent tissue sections (Table S1). The ion 
counts correspond to the signal intensity of the transition m/z 174→114 normalized to the 
ion counts of the transition m/z 177→116 (NAA-d3, the internal standard). The box 
represents the interquartile range with a median line and whiskers at ±1.5 SD. Squares 
represent the mean value. Circles represent outliers. Zero intensity was assigned to Sample 
#13 in which no NAA signal was detected (Table S1).
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Fig. 4. Case #19
(On the left) Negative ion mode full-scan mass spectra over m/z 760–920 of (A) Sample 
#31, pathological assignment: glioma 70% TCP. (D) Sample #32, pathological assignment: 
glioma 70% TCP (G) Sample #33, pathological assignment, grey matter with 40% TCP. 
Lipid profile spectra are normalized to the base peak (m/z 794, 788, and 834, respectively) 
over the mass range m/z 760–920. (Middle column) Negative ion mode product ion scan for 
NAA of (B) Sample #31, (E) Sample #32, (H) Sample #33. MS/MS product ion spectra are 
normalized to the signal of the signal intensity of the internal standard NAA-d3 (transition 
m/z 177→116). (On the right) Picture of Specimen #19 with superimposed annotation of the 
touch number for swab TS-MS analysis (C) Touch #1. (F) Touch #2. (I) Touch #3. The 
tissue was allowed to thaw at room temperature before performing the swab TS-MS 
analysis.
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Fig. 5. 2HG expression
(A) Box and whisker plot for 2HG in tissue analyzed by swab TS-MS. Wild-type, n=21; 
IDH-mutant gliomas, n=8. Normalized ion counts correspond to the signal intensity of the 
transition m/z 147→129→101 normalized to the signal intensity of the internal standard 
NAA-d3 (transition m/z 177→116). The box represents the interquartile range with a 
median line and whiskers at ±1.5 SD. Squares represent the mean value. (B) 2HG 
concentration (ng/mg tissue) from tissue extracts by ESI-MS versus 2HG normalized signal 
from swab TS-MS for 28 cases (Case #29 was of insufficient quantity to perform the 
quantitative measurement). Dark grey squares, wild-type gliomas; light grey circles, IDH-
mutant gliomas; black lines represent the cut-offs for the Logarithmic 2HG normalized 
signal intensity (horizontal line) and for the Logarithmic 2HG concentration (45 ng/mg, 
vertical line). The value of 0.001 was assigned to samples in which no 2HG signal was 
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detected in order to compute the logarithm (−3). 2HG concentrations are reported in Table 
S3 for validation.
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